Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 9/20 | 0.37 |
| ▸ | GNRHR | P30968 | 7/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7593479 | 0.92 | ADORA2B (0.39) | ADORA2BGNRHRKMT2AALDH1A1NPSR1 | |
| SCHEMBL7596779 | 0.90 | GNRHR (0.43) | GNRHRMEN1KMT2A | |
| SCHEMBL7597705 | 0.90 | MEN1 (0.37) | GNRHRMEN1KMT2AALDH1A1TP53 | |
| SCHEMBL7592912 | 0.89 | GNRHR (0.37) | GNRHRMEN1KMT2AALDH1A1 | |
| SCHEMBL7591161 | 0.89 | ADORA2B (0.40) | ADORA2BGNRHRMEN1KMT2AALDH1A1 | |
| SCHEMBL7593455 | 0.89 | GNRHR (0.36) | GNRHRMEN1KMT2AALDH1A1NPSR1 | |
| SCHEMBL7598723 | 0.89 | GNRHR (0.36) | GNRHRMEN1KMT2AALDH1A1NPSR1 | |
| SCHEMBL7854741 | 0.87 | ADORA2B (0.49) | ADORA2BMEN1KMT2ATP53 | |
| SCHEMBL7597312 | 0.87 | MEN1 (0.36) | ADORA2BGNRHRMEN1KMT2AALDH1A1 | |
| SCHEMBL7597198 | 0.86 | NPSR1 (0.37) | GNRHRMEN1KMT2AALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0846119-B1 | THIENOPYRIMIDINE DERIVATIVES, THEIR PRODUCTION AND USE AS ENDOTHELIN ANTAGONISTS | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2002-11-13 | — | — | EP | disclosed |